Genetic analysis and QTL mapping of growth period traits and plant height traits in soybean recombinant inbred lines from Dongnong 47 × PI 317334-B

High and stable yield is the main goal of soybean genetic improvement. In this study, association analysis was used to detect the quantitative trait loci (QTL) for the plant height, and soybean growth period using 182 SSR markers in the RIL population of 136 F_4:8 lines, which developed from a cross between photoperiod-insensitive cultivar ‘Dongnong 47’ and photoperiod-sensitive variety PI317334–B. The results showed that 33 QTLs related to soybean growth period and plant height traits were detected by compound interval mapping, and were located on 12 linkage groups including N, C1, C2, J, D1a, B2, E, G, A2, O, L, I, with the contribution rate of 7.85–33.84%. These QTL loci and linkage markers related to soybean photoperiod sensitivity, would be helpful to identify key genes that control soybean photoperiod sensitivity, and provide an important basis for the breeding of new photoperiod-insensitive soybean varieties based on molecular design breeding.     

Cross‐linked polyacrylates in post‐mining substrates: persistence and effects on plant growth

Application of hydrophilic polymers composed of cross‐linked polyacrylate can improve soil water‐holding capacity and accelerate the restoration of post‐mining substrates. In this work, we studied the persistence of a polyacrylate polymer incorporated into a soil and its impact on plant nutrients at a reclamation site of former lignite mining in Lusatia (Germany). In contrast to autumn application, the incorporation of the polymer enhanced the sequestration of plant‐derived carbon in the soil, which was reflected by a significant increase in the concentration of a lignin marker. Attenuated total reflexion–Fourier transform infrared spectra (ATR‐FTIR) and total elemental contents in the applied polymer suggested an intensive cation exchange between the polymer framework and the soil‐forming substrate. In addition, there was an enrichment of carbonaceous material, which seems to reduce the swelling and thus the water‐holding capacity of the cross‐linked polyacrylate. Conversely, this process protected the polymer structure from rapid decomposition.     

棉花单核苷酸多态性标记研究进展

单核苷酸多态性标记已在农作物研究中得到广泛应用并取得重大进展。为了便利棉花SNP(Single nucleotide polymorphism)标记的研究和应用,介绍了利用基因芯片、简化基因组测序、重测序等在棉花中开发SNP标记的方法 ,综述了SNP标记在棉花遗传图谱构建、数量位点的定位和分子标记辅助育种、基因组测序以及系统进化等研究中的应用。并对异源四倍体棉花中SNP标记开发时,同源序列位点和部分同源序列位点上的SNP标记辨别问题进行了系统探讨,对其快捷的开发、检测方式和在数量基因定位中的应用前景进行了展望。     

中华蜜蜂囊状幼虫病毒检测方法研究进展

中蜂囊状幼虫病是一种由中蜂囊状幼虫病毒引起的严重威胁中蜂健康的传染性疾病。目前由于该病尚无有效的药物治疗方式,因此,预防与及时检测对于遏制该病传播显得尤为重要。本文主要从临床诊断、分子生物学和免疫学方面总结中蜂囊状幼虫病检测与鉴定的方法,包括形态诊断、RT-PCR技术、实时荧光定量PCR、巢式PCR、胶体金免疫快速诊断技术、ELISA、血清学技术和基因芯片等,为中蜂囊状幼虫病毒检测方法的改进和优化提供参考。     

绵羊(ATAG)n四碱基微卫星位点的筛选及其在亲子鉴定中的应用

本试验旨在筛选绵羊高度多态性四碱基微卫星遗传标记,建立适用于绵羊亲子关系鉴定的实验体系。试验以小尾寒羊为主要研究对象,从已有的绵羊参考基因组序列出发,基于全基因组序列筛选法共筛选出53个（ATAG）_n四碱基重复微卫星位点,然后通过基因分型数据共筛选出30个扩增效果好、多态信息含量（PIC）丰富的四碱基重复微卫星位点;30个位点的基因分型结果表明,共扩增出253个等位基因,平均等位基因数为8.433,等位基因数均>5,多态信息含量在0.566~0.898,观测杂合度（Ho）范围在0.548~0.903,期望杂合度（He）范围在0.631~0.921,平均期望杂合度为0.776;哈代-温伯格平衡检验30个位点均处于遗传平衡状态。随后根据PCR的扩增效率从获得的30个多态性位点中筛选出22个微卫星位点用于亲权排除概率的计算,根据多态信息含量的大小由高到低依次增加位点数进行组合。结果表明,在两个亲本的基因型均未知的情况下,标记位点数为15个时,累积排除概率可达到99.99%,其中单个位点的第一非亲排除率（non-exclusion probability of the first parent,NE-1P）介于0.321~0.663之间。利用建立的亲子鉴定体系对16只具有系谱记录的小尾寒羊样本进行检测,结果共鉴定出4个具有高置信度的绵羊家系,鉴定结果与系谱记录完全一致。本试验为绵羊分子系谱的构建、亲子鉴定以及保障绵羊育种工作的正常开展奠定重要基础。     

松辽黑猪OAS1基因多态性及其与繁殖性状的关联分析

为探究寡腺苷酸合成酶1（oligoadenylate synthase 1,OAS1）基因多态性与松辽黑猪繁殖性状的关联性,试验选取130头松辽黑猪母猪为研究对象,利用Sanger直接测序法测序查找OAS1基因外显子1~8的SNP位点,使用SPSS 19.0软件分析OAS1基因SNP位点与松辽黑猪繁殖性状的关联性。结果显示,在松辽黑猪OAS1基因外显子2、3和6上共检测到33个突变位点;其中在外显子2的110 bp处存在1个SNP位点（G110C）,存在3种基因型：GG、GC和CC;在外显子3的176 bp处存在1个SNP位点（C176T）,存在3种基因型：CC、CT和TT;在外显子6的145 bp处存在1个SNP位点（C145T）,存在3种基因型：CC、CA和AA;在166 bp处存在1个SNP位点（G166A）,存在3种基因型：GG、GA和AA;在206 bp处存在1个SNP位点（A206G）,存在3种基因型：AA、AG和GG。卡方适合性检验结果显示,松辽黑猪OAS1基因G110C突变位点符合Hardy-Weinberg平衡状态,C176T、C145A、G166A和G206A位点均偏离Hardy-Weinberg平衡状态。群体遗传参数分析结果显示,各SNPs位点遗传杂合度均位于中等水平,为中度多态（0.25<PIC<0.5）。关联分析结果发现,G110C位点GC基因型个体总产仔数、产活仔数和断奶仔猪数均显著高于GG基因型个体（P<0.05）;C176T位点CT基因型个体断奶仔猪数显著高于CC基因型个体（P<0.05）;C145T位点CC基因型个体总产仔数和产活仔数均显著高于AA基因型个体（P<0.05）;G166A位点GA基因型个体断奶仔猪数显著高于GG基因型个体（P<0.05）;A206G位点GG基因型个体总产仔数和产活仔数显著高于AA基因型个体（P<0.05）。结果表明,OAS1基因外显子区存在突变位点,对松辽黑猪部分繁殖性状有显著性影响。     

应用分子靶点药物治疗犬肥大细胞瘤的研究进展

犬肥大细胞瘤因其恶性率和转移率都较高,并且常规化疗药物副作用较强,患犬生存期和生存质量显著下降,因此急需新型的药物进行治疗。近几年,治疗肿瘤的分子靶点药物凭借其疗效好、副作用低的特点,受到越来越广泛的关注,特别是在治疗犬肥大细胞瘤的应用中效果显著。论文重点介绍了欧美小动物临床最常用的伊马替尼、托赛拉尼、马赛替尼这3种以异常KIT为靶点的药物及其药物作用机理及药效,最后介绍了由c-kit基因二次突变所导致的耐药问题及其预防措施,期望能对我国小动物临床医师和科研工作者有所启发。     

Serum C-reactive protein concentration as an indicator of remission status in dogs with multicentric lymphoma

BACKGROUND: The acute-phase protein C-reactive protein (CRP) is used as a diagnostic and prognostic marker in humans with various neoplasias, including non-Hodgkin's lymphoma. OBJECTIVE: To evaluate if CRP could be used to detect different remission states in dogs with lymphoma. ANIMALS: Twenty-two dogs with untreated multicentric lymphoma. METHODS: Prospective observational study. Blood samples were collected at the time of diagnosis, before each chemotherapy session, and at follow-up visits, resulting in 287 serum samples. RESULTS: Before therapy, a statistically significant majority of the dogs (P = .0019) had CRP concentrations above the reference range (68%, 15/22). After achieving complete remission 90% (18/20) of the dogs had CRP concentrations within the reference range, and the difference in values before and after treatment was statistically significant (P < .001). CRP concentrations of dogs in complete remission (median, 1.91; range, 0.2-103) were significantly different (P = .031) from those of dogs with partial remission (median, 2.48; range, 0-89), stable disease (median, 1.77; range, 1.03-42.65), or progressive disease (median, 8.7; range, 0-82.5). There was profound variation of CRP measurements within each dog. CONCLUSIONS: CRP is useful in determining complete remission status after treatment with cytotoxic drugs. However, the individual variation between dogs means CRP concentration is not sufficiently different in other remission states to permit its use in monitoring progression of the disease. Greater reliability in determining remission status might be achieved by combining CRP concentration with other serum markers.